Literature DB >> 23399467

Relationship of opioid prescription sales and overdoses, North Carolina.

F Modarai1, K Mack, P Hicks, S Benoit, S Park, C Jones, S Proescholdbell, A Ising, L Paulozzi.   

Abstract

BACKGROUND: In the United States, fatal drug overdoses have tripled since 1991. This escalation in deaths is believed to be driven primarily by prescription opioid medications. This investigation compared trends and patterns in sales of opioids, opioid drug overdoses treated in emergency departments (EDs), and unintentional overdose deaths in North Carolina (NC).
METHODS: Our ecological study compared rates of opioid sales, opioid related ED overdoses, and unintentional drug overdose deaths in NC. Annual sales data, provided by the Drug Enforcement Administration, for select opioids were converted into morphine equivalents and aggregated by zip code. These opioid drug sales rates were trended from 1997 to 2010. In addition, opioid sales were correlated and compared to opioid related ED visits, which came from a Centers for Disease Control and Prevention syndromic surveillance system, and unintentional overdose deaths, which came from NC Vital Statistics, from 2008 to 2010. Finally, spatial cluster analysis was performed and rates were mapped by zip code in 2010.
RESULTS: Opioid sales increased substantially from 1997 to 2010. From 2008 to 2010, the quarterly rates of opioid drug overdoses treated in EDs and opioid sales correlated (r=0.68, p=0.02). Specific regions of the state, particularly in the southern and western corners, had both high rates of prescription opioid sales and overdoses.
CONCLUSIONS: Temporal trends in sales of prescription opioids correlate with trends in opioid related ED visits. The spatial correlation of opioid sales with ED visit rates shows that opioid sales data may be a timely way to identify high-risk communities in the absence of timely ED data.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Drug; North Carolina; Opiates; Opiods; Overdoses; Prescription drugs

Mesh:

Substances:

Year:  2013        PMID: 23399467     DOI: 10.1016/j.drugalcdep.2013.01.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  26 in total

1.  Investigating the Social Ecological Contexts of Opioid Use Disorder and Poisoning Hospitalizations in Pennsylvania.

Authors:  Christina Mair; Natalie Sumetsky; Jessica G Burke; Andrew Gaidus
Journal:  J Stud Alcohol Drugs       Date:  2018-11       Impact factor: 2.582

Review 2.  The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse.

Authors:  Ellen M Soffin; Bradley H Lee; Kanupriya K Kumar; Christopher L Wu
Journal:  Br J Anaesth       Date:  2018-12-28       Impact factor: 9.166

3.  Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.

Authors:  Benedikt Fischer; Jürgen Rehm; Mark Tyndall
Journal:  CMAJ       Date:  2016-11-07       Impact factor: 8.262

4.  The Evolution of BioSense: Lessons Learned and Future Directions.

Authors:  Deborah W Gould; David Walker; Paula W Yoon
Journal:  Public Health Rep       Date:  2017 Jul/Aug       Impact factor: 2.792

5.  Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.

Authors:  Corey S Davis; Derek Carr; Jessica K Southwell; Leo Beletsky
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

Review 6.  Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review.

Authors:  Nicholas B King; Veronique Fraser; Constantina Boikos; Robin Richardson; Sam Harper
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

7.  Physician Dispensing of Oxycodone and Other Commonly Used Opioids, 2000-2015, United States.

Authors:  Karin Ann Mack; Christopher McCall Jones; Roderick John McClure
Journal:  Pain Med       Date:  2018-05-01       Impact factor: 3.750

8.  Hot spots in mortality from drug poisoning in the United States, 2007-2009.

Authors:  Lauren M Rossen; Diba Khan; Margaret Warner
Journal:  Health Place       Date:  2013-12-01       Impact factor: 4.078

9.  Assessing Spatial Relationships between Prescription Drugs, Race, and Overdose in New York State from 2013 to 2015.

Authors:  Phillip L Marotta; Tim Hunt; Louisa Gilbert; Elwin Wu; Dawn Goddard-Eckrich; Nabila El-Bassel
Journal:  J Psychoactive Drugs       Date:  2019-05-05

10.  Drug overdose surveillance using hospital discharge data.

Authors:  Svetla Slavova; Terry L Bunn; Jeffery Talbert
Journal:  Public Health Rep       Date:  2014 Sep-Oct       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.